Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q2 FY24 results · Jul–Sep 2023

Insecticides (India) reported revenue from operations of ₹695.99 crore (up 19.5% from Q2 FY23) and net profit of ₹53.15 crore (up 18.6% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY24Q2 FY23YoYQ1 FY24QoQ
Revenue from operations695.99582.21+19.5%639.95+8.8%
Other income(0.17)0.28Turned loss3.89Turned loss
Total income695.81582.49+19.5%643.84+8.1%
Profit before share of associates & JVs and tax71.5559.60+20.0%39.49+81.2%
Share of profit/(loss) of associates & JVs0.200.170.11
Net profit for the period53.1544.83+18.6%29.14+82.4%
EPS, basic (₹)17.9515.15not comparable9.85+82.2%
Net margin (%)7.67.74.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ2 FY24Q2 FY23YoYQ1 FY24QoQ
Revenue from operations695.99582.21+19.5%639.95+8.8%
Other income(0.17)0.28Turned loss3.89Turned loss
Total income695.81582.49+19.5%643.84+8.1%
Profit before tax71.9059.60+20.6%39.49+82.1%
Net profit for the period53.2444.67+19.2%29.03+83.4%
EPS, basic (₹)17.9915.09not comparable9.81+83.4%
Net margin (%)7.67.74.5
Consolidated
Filed with BSE
17 Nov 2023, 15:53 IST
Board meeting
02 Nov 2023
Period
01 Jul 2023 to 30 Sep 2023
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
17 Nov 2023, 15:53 IST
Board meeting
02 Nov 2023
Period
01 Jul 2023 to 30 Sep 2023
Review status
Unaudited
Source
XBRL filing on BSE